ASM23 highlights

ASM23 Convenor A/Prof Zarnie Lwin

“Shifting The Dial Forward in Lung Cancer Care: It Takes a village” Highlights of the 2023 Annual Scientific Meeting The TOGA 2023 Annual Scientific Meeting highlighted that it truly takes a village to treat lung cancer as it showcased the latest research in immuno- and targeted therapy, thoracic surgery, respiratory medicine, palliative and supportive care […]

Lung Cancer Screening Program: Early Detection Saves Lives

The hand of a doctor is cradling a scanned image of lungs

On May 2, 2023, the Australian Government announced a significant investment of $263.8 million over four years to establish the national Lung Cancer Screening Program (LCSP). This program aims to improve early detection of lung cancer, the leading cause of cancer death in Australia.

MSAC Recommendation for NGS panel testing

Recommendation for improved genetic testing for Non-Small Cell Lung Cancer Patients Recommendation by the Medical Services Advisory Committee (MSAC) Why is gene testing important for lung cancer patients? Non-small cell lung cancer (NSCLC) accounts for about 80% to 85% of lung cancers. The main subtypes of NSCLC are adenocarcinoma, squamous cell carcinoma, or large undifferentiated […]

ASM 2023 Program

ASM23 Speakers

Submit an Abstract Back to 2023 ASM ASM 2023 Program We are pleased to announce that the following speakers have confirmed their participation in the TOGA ASM 2023. We are delighted that the two international speakers, Professors Karen Kelly and Stephen Swisher, have accepted our invitations and will be joining us in-person at the TOGA […]

ASM22 highlights

ASM22 Convenor Dr Melissa Moore and A/Prof Zarnie Lwin

2022 Annual Scientific Meeting Highlights The Dynamic Face of Lung Cancer was certainly showcased at our 2022 Annual Scientific Meeting, with presentations illustrating the latest research and clinical practice in surgery, diagnostics, radiation therapy, targeted therapy, immunotherapy and prevention of risk factors for thoracic cancers. Held as a ‘hybrid’ event, the event attracted 150 face […]

Run and fundraise

Running for #TeamTOGA What is #TeamTOGA? #TeamTOGA is a group of individuals who walk or run to raise money for lung cancer and mesothelioma research by participating in marathons or walking events and collecting donations and sponsors through their own personal fundraising page created by TOGA. #TeamTOGA is reassembling for the 2023 Sun Herald City2Surf, […]


Abstract Submission Guidelines Back to 2023 ASM Abstract Submissions The TOGA Annual Scientific Meeting (ASM) Local Organising Committee (LOC) welcomes abstracts on any scientific study of merit for submission, particularly those that provide new and original data relevant to the Australian and New Zealand environment.  Abstracts may be submitted on any topic relevant to lung […]


Research Prioritisation in Lung Cancer Survivorship With the advent of new and more effective lung cancer treatments in the last 10 years and the emerging data supporting screening, there is, and will continue to be, a growing number of lung cancer survivors who either have had surgery or radiotherapy for early disease, and/or remain on […]


Australian Cancer Plan 2023-2033 The Australian Cancer Plan The Minister for Health and Aged Care, the Hon. Greg Hunt MP, has invited Cancer Australia to develop a modernised Australian Cancer Plan. This recognises the need for an overarching national approach to cancer control that meets the needs of all Australians now and in the future, […]


Mobilising teletrials What are teletrials? Teletrials, also known as digi trials, are when a clinician at a primary site uses telehealth (videoconference or telephone calls) to enrol, consent, treat and/or follow up patients at another site, referred to as a satellite site. However, much of the responsibility for the clinical trial remains at the primary […]